Securities code: Zhejiang Gongdong Medical Technology Co.Ltd(605369) securities abbreviation: Zhejiang Gongdong Medical Technology Co.Ltd(605369) Announcement No.: 2022010 Zhejiang Gongdong Medical Technology Co.Ltd(605369)
Announcement of resolutions of the 15th meeting of the second board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
All directors of the company attended the meeting
All the proposals of the board of directors were passed without negative vote or abstention
1、 Meetings of the board of directors
Zhejiang Gongdong Medical Technology Co.Ltd(605369) (hereinafter referred to as “the company”) the 15th meeting of the second board of directors was held by on-site voting in the conference room on the third floor of the company on April 15, 2022. The notice of the meeting was sent by hand or email on April 3, 2022. The meeting was presided over by Mr. Shi Huiyong, chairman of the board. There were 7 directors who should attend the meeting and 7 directors who actually attended the meeting. Supervisors and senior managers of the company attended the meeting as nonvoting delegates. The convening and convening of this meeting comply with the relevant provisions of the company law and the articles of association, and the contents of the resolution are legal and valid.
2、 Deliberations of the board meeting
(I) the proposal on the appointment of the company’s chief financial officer was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
Agree to appoint Mr. Pan Lei as the chief financial officer of the company.
Independent directors expressed their independent opinions on the proposal.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on changing the chief financial officer of the company (Announcement No.: 2022009).
(II) the proposal on the company’s 2021 annual report and its summary was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The company’s 2021 annual report and the company’s 2021 annual report summary.
(III) the proposal on the work report of the board of directors in 2021 was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
(IV) the proposal on the work report of the general manager of the company in 2021 was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
(V) the proposal on the report on the work of independent directors of the company in 2021 was deliberated and adopted. The voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Report on the work of independent directors of the company in 2021.
(VI) the proposal on the performance report of the audit committee of the board of directors in 2021 was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Report on the performance of the audit committee of the board of directors in 2021.
(VII) the proposal on the company’s internal control evaluation report in 2021 was considered and adopted. The voting results: 7 in favor, 0 against and 0 abstention.
Independent directors expressed their independent opinions on the proposal.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) 2021 annual internal control evaluation report of the company.
(VIII) deliberated and passed the proposal on the company’s 2021 annual financial statement report
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
(IX) the proposal on the company’s profit distribution plan for 2021 was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The company plans to distribute a cash dividend of 13.80 yuan (including tax) to all shareholders for every 10 shares.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Announcement of annual profit distribution plan (Announcement No.: 2022012).
(x) the proposal on renewing the appointment of financial audit institutions was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The independent directors have expressed their prior approval opinions and independent opinions, and the proposal needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on renewing the appointment of accounting firms (Announcement No.: 2022013).
（11） The proposal on the special report on the annual deposit and use of raised funds (2021) was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
Independent directors expressed their independent opinions on the proposal.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Special report on the annual storage and use of raised funds (2021) (Announcement No.: 2022014). （12） The proposal on confirming the daily connected transactions of the company in 2021 and the expected daily connected transactions of the company in 2022 was reviewed and approved
Voting results: 6 in favor, 0 against and 0 abstention.
According to the company’s business needs, in 2022, the company expects to have daily related party transactions with the related party Zhejiang Evergrande Medical Devices Co., Ltd. with a total amount of no more than 21 million yuan.
Independent directors have expressed their prior approval opinions and independent opinions, and related director Shi Huiyong avoided voting. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on expected daily connected transactions in 2022 (Announcement No.: 2022015).
（13） The proposal on the remuneration of directors and senior managers of the company was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
Independent directors expressed their independent opinions on the proposal.
The remuneration of the company’s directors needs to be submitted to the general meeting of shareholders for deliberation.
（14） The proposal on the company’s financing limit and guarantee was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
（15） The proposal on the company’s use of idle self owned funds to purchase financial products and long-term foreign exchange settlement and sales was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
（16） The proposal on formulating the company’s shareholder return plan for the next three years (20222024) was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
Independent directors expressed their independent opinions on the proposal.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The company’s shareholder return plan for the next three years (20222024).
（17） The proposal on Amending the articles of association was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on Amending the articles of association and its annexes (Announcement No.: 2022016).
（18） The proposal on Amending the rules of procedure of the general meeting of shareholders was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on Amending the articles of association and its annexes (Announcement No.: 2022016).
（19） The report of the company for the first quarter of 2022 was reviewed and approved
Voting results: 7 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The first quarter report of the company in 2022.
（20） The proposal on convening the 2021 annual general meeting of shareholders of the company was deliberated and adopted
Voting results: 7 in favor, 0 against and 0 abstention.
The company plans to hold the 2021 annual general meeting of shareholders in the conference room on the third floor of the company at 14:00 p.m. on May 10, 2022.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Notice on convening the company’s 2021 annual general meeting of shareholders (Announcement No.: 2022017).
It is hereby announced.
Zhejiang Gongdong Medical Technology Co.Ltd(605369) board of directors April 18, 2022
